Radar · Life Sciences in Austin
Best Life Sciences Companies in Austin, United States
The 221 best Life Sciences companies in Austin, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Everlywell.
By Riya SenguptaFinancials
221companies tracked
$3.2Bdisclosed funding
1unicorns
100have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × AUSTIN
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
164companies analysed
83%cloud-native stacks
2025funding peak (by rounds)
7unicorns
2016median founding year
275kcombined LinkedIn audience
35%of audience held by top 3
1companies hiring publicly (12 mo)
Ranked: Best Life Sciences companies in Austin
| # | Company | Disclosed funding | Last round | Employees | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|
| 1 | Everlywell 🦄 Provider of home-based diagnostic tests for the detection of various diseases | $330M | 65 mo ago | 614 | Julia Cheek Founder & CEO | — | — |
| 2 | Luminex Developer of instruments, reagents and kits for clinical diagnostics and life science research | $279M | 63 mo ago | 1,004 1,004 → 1,010 (+1%) · sector median +14% | — | 859 patents Multiplexed nucleic acid detection and analysis using advanced probes and imaging technologies. | 4 launchs |
| 3 | Shattuck Labs Developer of an immunotherapy platform for oncology and other diseases | $165M | 9 mo ago | 89 89 → 57 (-36%) · sector median +14% | — | 305 patents Bispecific immunomodulatory antibodies and TRIM7‑targeted protein therapeutics, including mRNA formats. | — |
| 4 | Savara Pharma Developer of therapeutics for rare respiratory diseases | $107M | 78 mo ago | 37 | Matt Pauls CEO | — | 1 partnership |
| 5 | Digital Pharmacist Platform offering CRM software for pharmacies | $106M | 87 mo ago | 213 | — | — | — |
| 6 | Lung Therapeutics Therapeutics for rare lung diseases include Pleural Effusion, Acute Lung Injury and Idiopathic Pulmonary… | $103M | 50 mo ago | 24 | Brian Windsor CEO | — | — |
| 7 | Aspira Women's Health Provider of diagnostic solution for ovarian malignancy in women 32Funding top 29%Tech top 46%Market bottom 46%Fin. health bottom 36% All 7 signals ▾Fundingtop 29% Techtop 46% Marketbottom 46% Fin. healthbottom 36% Growthbottom 35% Globalbottom 30% Newsbottom 21% Funding: Raised $96.7M across 8 rounds · 8 rounds over 16 yrs (0.5/yr) Tech: 36 technologies across 4/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 32/100 | $97M | 9 mo ago | 85 85 → 60 (-29%) · sector median +14% | — | — | 2 partnerships |
| 8 | Embark Veterinary Proivder of DNA test kits for dogs that enable dog owners to provide better pet care | $94M | 58 mo ago | 141 | Amish Desai Chief Executive Officer | 20 patents Canine genetic testing platforms for pigmentation and ancestry phenotype prediction | — |
| 9 | Nano Provider of vaccine development and management devices for researchers | $90M | 63 mo ago | 27 | Steve Papermaster CEO & Chairman | 243 patents Nanomaterial-based conductive inks, transparent electrodes, and optoelectronic films | — |
| 10 | Apollo Endo Developer of therapeutic devices for obesity and other GI disorders | $80M | 71 mo ago | 132 | — | — | — |
| 11 | Asuragen Molecular diagnostics and genetics company advancing precision medicine in oncology | $80M | 80 mo ago | 114 114 → 101 (-11%) · sector median +14% | — | 351 patents Detecting and analyzing repeat-rich nucleic acids and miRNA biomarkers for diagnostics. | 1 partnership |
| 12 | Mirna Therapeutics Developing microRNA-based oncology therapies for solid and hematologic cancers | $78M | 133 mo ago | 27 | Jose Carlos Gutierrez Ramos CEO & President | — | — |
| 13 | Mirna Therapeutics Developing microRNA-based therapeutics for cancer treatment. | $78M | 133 mo ago | 72 | — | — | — |
| 14 | Arthrocare Products for sports medicine and ENT disorders | $75M | 202 mo ago | 1,840 | — | 761 patents Knotless soft‑tissue repair devices and electrosurgical systems for orthopedic surgery | — |
| 15 | Pattern Bioscience Provider of multiple diagnostics platforms for infectious diseases 60Patents top 20%Funding top 25%Innovation top 26%Moat top 32% All 10 signals ▾Patentstop 20% Fundingtop 25% Innovationtop 26% Moattop 32% Growthtop 37% Talenttop 38% Techbottom 46% Marketbottom 38% Globalbottom 38% Newsbottom 22% Patents: 58 patents matched (strict assignee match) · 42 filings since 2022 vs 16 in 2017-21 Funding: Raised $68.0M across 7 rounds · 7 rounds over 7 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 60/100 | $68M | 10 mo ago | 58 58 → 77 (+33%) · sector median +14% | Ross Johnson Co-Founder | 58 patents Microfluidic single-cell analysis platforms for diagnostic and phenotypic screening | 1 award |
| 16 | IntraBio Developer of therapies for treating rare and neurodegenerative diseases | $60M | 31 mo ago | 4 | — | 6 patents Therapeutic use of N‑acetyl‑leucine for rare neurodegenerative and lysosomal disorders | — |
| 17 | Aeglea Developer of drugs for rare metabolic disorders | $56M | 117 mo ago | 81 | — | — | — |
| 18 | Triumvira Immunologics Developer of T-cell therapies for treating cancers | $55M | 51 mo ago | 85 | Jonathan Bramson Co-Founder & Chairman | 48 patents Bispecific T‑cell engager antibodies targeting Claudin‑18.2, GUCY2C, and GPC3 for cancer immunotherapy. | — |
| 19 | L7 Informatics Provider of a clinical trail workflow management software for laboratories | $55M | 48 mo ago | 126 126 → 112 (-11%) · sector median +14% | Vasu Rangadass President & CEO | 5 patents Intelligent object-based information platforms and semantic knowledgebases for data access | 2 awards |
| 20 | Endocare Provider of cancer diagnostic and therapeutic instruments | $53M | 228 mo ago | 120 | — | 193 patents Cryogenic and microwave ablation devices for minimally invasive surgical tumor treatment | — |
| 21 | Season Health Online platform offering dietician virtual consultation services | $52M | 30 mo ago | 50 50 → 83 (+66%) · sector median +14% | Mustafa Shabib Co-Founder & CTO | — | — |
| 22 | Ascension Orthopedics Diagnostics leader transforming data into actionable insights for a healthier future | $49M | 179 mo ago | 12 | — | 89 patents Orthopedic bone fixation implants and surgical instruments for fracture repair and joint resurfacing | — |
| 23 | VUV Analytics Provider of vacuum ultraviolet absorption spectroscopic instruments | $48M | 40 mo ago | 36 | Dale Harrison Co-Founder & CTO | 42 patents VUV absorption spectroscopy systems and flow cells for high‑sensitivity liquid analysis. | — |
| 24 | SubjectWell Provider of clinical trials marketplace offering solutions for patient recruitment | $47M | 44 mo ago | 195 | Fred Martin CEO | — | — |
| 25 | Inova Labs Oxygen concentrators for patients with respiratory disorders | $45M | 144 mo ago | 66 | — | 154 patents Therapeutic compression devices and oxygen concentrator technologies for circulatory and respiratory care | — |
| 26 | Babson Diagnostics Provider of blood testing service using microsamples collected from a finger. | $45M | 59 mo ago | 57 57 → 54 (-5%) · sector median +14% | Eric Olson Founder | 22 patents Automated blood sample handling and centrifugation for point‑of‑care diagnostics | 1 launch · 1 partnership |
| 27 | Forbius Biotech innovator dedicated to advancing healthcare solutions for better health | $32M | 80 mo ago | 37 | — | — | — |
| 28 | OsteoCentric Developer of orthopedic medical implants | $32M | 56 mo ago | 64 64 → 73 (+14%) · sector median +14% | Eric Brown Founder & CEO | — | — |
| 29 | Form Bio Cloud-based data management tool for providers | $30M | 44 mo ago | 49 | Kent Wakeford Co-Founder & Co-CEO | — | 1 launch |
| 30 | Monogram Developer of robotic surgical systems and personalized 3D-printed orthopedic implants | $30M | 52 mo ago | 20 20 → 23 (+15%) · sector median +14% | Douglas Unis Founder | — | — |
| 31 | Cassava Sciences Developer of small molecule-based therapeutic solutions for treating neurological diseases | $27M | 61 mo ago | 24 | Remi Barbier CEO & President | — | — |
| 32 | PLUS THERAPEUTICS Provider of therapeutics for multiple cancer treatments | $24M | 16 mo ago | 20 20 → 27 (+35%) · sector median +14% | Marc Hedrick CEO | — | 1 partnership |
| 33 | TFF Pharmaceuticals Developer of inhalation products for chronic respiratory diseases | $22M | 35 mo ago | 15 | Harlan Weisman CEO | — | — |
| 34 | Nuclein Developer of handheld PCR device for the detection of infectious disease | $20M | 11 mo ago | 27 | Alan Blake Chief Executive Officer | 24 patents Molecular diagnostic kits: nucleic acid extraction, amplification, and reagent stabilization. | 1 expansion |
| 35 | QbDVision Provider of a platform for process management software for pharma manufacturing 42Funding top 36%Talent top 38%Moat top 39%Growth top 45% All 8 signals ▾Fundingtop 36% Talenttop 38% Moattop 39% Growthtop 45% Techtop 49% Marketbottom 39% Globalbottom 29% Newsbottom 27% Funding: Raised $20.0M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 42/100 | $20M | 14 mo ago | 43 | Ryan Shillington Co-Founder and CTO | — | 1 partnership · 1 award |
| 36 | Fourth Frontier Provider of a connected wearable device for cardiac health monitoring | $15M | 59 mo ago | 48 48 → 76 (+58%) · sector median +14% | Manav Bhushan Co-Founder & Co-CEO | — | 5 job openings |
| 37 | Harmonic Bionics Developer of robotic rehabilitation systems designed for upper extremity therapy | $13M | 48 mo ago | 26 | — | 21 patents Patents concentrated in health & consumer products | — |
| 38 | MaxWell Biosciences Engineering personalized human blood to optimize cognitive performance and reverse Alzheimer's disease | $11M | 10 mo ago | 13 | — | 55 patents Peptoid-based antimicrobials and anti‑biofilm coatings for medical and wound applications | — |
| 39 | Curative Provider of self collecting COVID-19 testing centers listing platform 48Tech top 20%Innovation top 31%Patents top 33%News top 39% All 11 signals ▾Techtop 20% Innovationtop 31% Patentstop 33% Newstop 39% Fundingtop 42% Growthtop 42% Producttop 49% Moatbottom 44% Marketbottom 43% Globalbottom 33% Fin. healthbottom 14% Tech: 40 technologies across 6/8 capability areas · Cloud: Amazon Web Services, Cloudflare Innovation: 10 patents (top 47% of patent-holders) · 8 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 48/100 | $10M | 7 mo ago | 2,251 | — | 10 patents Molecular diagnostics: nucleic acid purification, sample collection kits, and infection/immunity testing devices. | 1 award |
| 40 | VISIE Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery 42Talent top 28%Innovation top 30%Patents top 32%Funding top 36% All 8 signals ▾Talenttop 28% Innovationtop 30% Patentstop 32% Fundingtop 36% Moattop 38% Techbottom 44% Globalbottom 36% Marketbottom 25% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Innovation: 17 patents (top 49% of patent-holders) · 17 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 42/100 | $10M | 13 mo ago | — | Aaron Bernstein Co-Founder & CTO | 17 patents Patents concentrated in computing, sensing & instrumentation | — |
| 41 | HeartSciences Provider of a screening device for the early detection of cardiac dysfunction | $8M | 31 mo ago | 12 12 → 23 (+92%) · sector median +14% | Mark Hilz CEO | 3 patents Non‑invasive ECG algorithms for deriving echocardiographic measurements and quantitative cardiac assessment | 3 launchs · 1 partnership |
| 42 | ClearCam ClearCam: Improving surgical vision with in-vivo laparoscope lens cleaning | $7M | 15 mo ago | 11 | Doug Stoakley Co-Founder | 81 patents Automated cleaning systems for medical imaging sensor elements | — |
| 43 | MedScout Provider of sales enablement platform to life sciences companies 22Funding top 34%Moat top 48%Talent bottom 49%Product bottom 48% All 8 signals ▾Fundingtop 34% Moattop 48% Talentbottom 49% Productbottom 48% Techbottom 46% Globalbottom 32% Marketbottom 29% Newsbottom 18% Funding: Raised $5.8M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) Moat: Editorial + unicorn rating 5/10 · 9 curated direct competitors tracked rank vs industry peers · Fliar Intelligence Index 22/100 | $6M | 3 mo ago | 17 | Skylar Talley Co-Founder & CEO | — | 1 partnership |
| 44 | Nurocor Developer of a clinical platform designed to accelerate clinical development 40Innovation top 29%Patents top 31%Moat top 32%Funding top 36% All 9 signals ▾Innovationtop 29% Patentstop 31% Moattop 32% Fundingtop 36% Producttop 36% Talentbottom 49% Marketbottom 36% Techbottom 35% Globalbottom 31% Innovation: 24 patents (top 39% of patent-holders) · 24 filings since 2022 vs 0 in 2017-21 Patents: 24 patents matched (strict assignee match) · 24 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 40/100 | $5M | 11 mo ago | 43 | Alex Lazar Founder & President | 24 patents Clinical trial software platforms: UI, code generation, and specimen management tools. | — |
| 45 | Aether Therapeutics Developer of therapeutics for the treatment of Neonatal Abstinence Syndrome | $4M | 29 mo ago | — | Rick Hawkins Co-Founder | — | 1 award |
| 46 | Autonomize AI-based drug discovery tool for researchers 53Talent top 31%Growth top 35%News top 38%Tech top 39% All 9 signals ▾Talenttop 31% Growthtop 35% Newstop 38% Techtop 39% Fundingtop 43% AItop 45% Moattop 48% Globalbottom 32% Marketbottom 29% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $4M | 12 mo ago | 18 | Ganesh Padmanabhan Co-Founder | — | 1 award |
| 47 | Health Discovery Labs Developed electrical muscle stimulation for ICU acquired weakness | $3M | 15 mo ago | — | Oussama Hassan Co-Founder & CMO | 101 patents AI-powered cancer diagnostics and genomic/flow cytometry data analysis tools | 1 award |
| 48 | NeuroX1 Computational drug design platform for neurological conditions | $2M | 24 mo ago | 7 | Lucas Myers Co-Founder & CTO | — | — |
| 49 | Mati Therapeutics Developing sustained drug delivery platform for ocular diseases, improving patient outcomes | $2M | 9 mo ago | — | Bob Butchofsky Founder and CEO | 165 patents Ocular sustained‑release drug delivery systems and lacrimal duct implant technologies. | — |
| 50 | Via Therapeutics Developer of novel drug delivery technologies | $1M | 22 mo ago | — | John Koleng Co-Founder & CSO | — | — |
Top 12 Life Sciences companies in Austin
#1
Public · Austin, Texas · founded 2016 · 89 employees$165.4Mraised▾
Public · Austin, Texas · founded 2016 · 89 employees
Shattuck Labs is a developer of an immunotherapy platform for oncology and other diseases. The company has developed ARC (Agonist Redirected Checkpoints), which hinges on the development of bispecific biologics that simultaneously block candidate checkpoint molecules in cancer while also stimulating TNF superfamily costimulatory receptors on T cells and innate cells. The company claims that ARC is adaptable to most of the checkpoint targets currently in clinical development.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers
Funding rounds
- Aug 2025Post IPO$103M
- Jun 2020Series C$83M
- Feb 2020Series B$25.4M
- May 2018Series B$46.6M
Investors
Hunter Trust, Redmile Group, Janus Henderson Investors, Fidelity Investments, EcoR1, Hatteras Venture Partners
#2
Public · Austin, Texas · founded 1993 · 85 employees$96.7Mraised▾
Public · Austin, Texas · founded 1993 · 85 employees
Provider of diagnostic solution for ovarian malignancy in women. It offers products OVA1 and OVERA to detect the risk of ovarian cancer for patients. It also offers its flagship product for the detection of risk heredity breast and ovary cancer; ASPiRA GenetiXSM testing which offers comprehensive genetic testing options with a gynecologic focus.
Fliar Intelligence Index™ 32how this company ranks against its industry peers
Funding
top 29%Tech
top 46%Market
bottom 46%Fin. health
bottom 36%Growth
bottom 35%Global
bottom 30%Funding: Raised $96.7M across 8 rounds · 8 rounds over 16 yrs (0.5/yr) · Last round Post IPO (Sep 2025)
Tech: 36 technologies across 4/8 capability areas · Cloud: Cloudflare · Security: Hsts
Market: 85 employees (top 40% of Genomics) · Revenue ~$9.2M · Top-10,000,000 web property
Audience (LinkedIn): 6k LinkedIn followers — 2.3% of this cohort's audience
Activity (LinkedIn): 2 partnerships (incl. Chelton Clinic) announced in 12 mo
Funding rounds
- Sep 2025Post IPO$3M
- Mar 2025Post IPO$1.4M
- Jun 2024Post IPO$1.9M
- Jul 2020Post IPO$11M
Tech stack
Apple Icloud MailBeaver BuilderCloudflareCore-JsDocusignFacebook Login
#3
Series C · Austin, Texas · founded 2016 · 58 employees$68Mraised▾
Series C · Austin, Texas · founded 2016 · 58 employees
Pattern is a provider of multiple diagnostics platforms for infectious diseases. It provides digital culture technology that combines single-cell analysis with AI pattern recognition to bypass time-consuming culture steps. It provides solutions technology to fight against antibiotic resistance.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Patents
top 20%Funding
top 25%Innovation
top 26%Moat
top 32%Growth
top 37%Talent
top 38%Patents: 58 patents matched (strict assignee match) · 42 filings since 2022 vs 16 in 2017-21 · Latest publication 2026
Funding: Raised $68.0M across 7 rounds · 7 rounds over 7 yrs (1.0/yr) · Last round Series C (Jul 2025)
Innovation: 58 patents (top 28% of patent-holders) · 42 filings since 2022 vs 16 in 2017-21
Audience (LinkedIn): 6k LinkedIn followers — 2.3% of this cohort's audience
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Jul 2025Series C$44.2M
- Apr 2023Series C$28.7M
- Jul 2020Series B$9M
- Feb 2020Series A$6.8M
Founders & team
Investors
CARB-X, Illumina Ventures, Dale Shaw, AMR Action Fund, Omnimed
Tech stack
CloudflareCloudflare Bot ManagementContact Form 7Core-JsDiviGoogle Analytics
#4
Series A · Austin, Texas · founded 2021 · 17 employees$5.8Mraised▾
Series A · Austin, Texas · founded 2021 · 17 employees
Provider of sales enablement platform to life sciences companies. The platform enables members to find and prioritize the physicians and facilities, send representatives into every conversation, build the strategy on detailed insights, build and manage prospect lists and territories and manage the information in the CMS platform.
Fliar Intelligence Index™ 22how this company ranks against its industry peers
Funding
top 34%Moat
top 48%Talent
bottom 49%Product
bottom 48%Tech
bottom 46%Global
bottom 32%Funding: Raised $5.8M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) · Last round Series A (Feb 2026)
Moat: Editorial + unicorn rating 5/10 · 9 curated direct competitors tracked
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Audience (LinkedIn): 4k LinkedIn followers
Activity (LinkedIn): 1 partnerships (incl. Telix Pharmaceuticals Limited) announced in 12 mo
Funding rounds
- Feb 2026Series A$10M
- Jul 2024Series A$15M
- Jun 2023Seed$5M
- Jun 2021Seed$800K
Founders & team
Investors
Live Oak Ventures, Stage 2 Capital, Alumni Ventures, Andreessen Horowitz, Fulcrum Equity Partners
Tech stack
CloudflareCloudflare Bot ManagementCore-JsGoogle AnalyticsGoogle Tag ManagerGoogle Workspace
#5
Series B · Austin, Texas · founded 2020 · 2251 employees$9.8Mraised▾
Series B · Austin, Texas · founded 2020 · 2251 employees
Provider of self collecting COVID-19 testing center listing platform. Users can find a COVID-19 testing center in their locality, book a schedule for a test, and give the samples for testing. The test results can be collected by the users later.
Fliar Intelligence Index™ 48how this company ranks against its industry peers
Tech
top 20%Innovation
top 31%Patents
top 33%News
top 39%Funding
top 42%Growth
top 42%Tech: 40 technologies across 6/8 capability areas · Cloud: Amazon Web Services, Cloudflare · Observability: Datadog, Sentry
Innovation: 10 patents (top 47% of patent-holders) · 8 filings since 2022 vs 0 in 2017-21
Patents: 10 patents matched (strict assignee match) · 8 filings since 2022 vs 0 in 2017-21 · Latest publication 2024
Audience (LinkedIn): 34k LinkedIn followers — 12.4% of this cohort's audience
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Oct 2025Series B$152.5M
- Sep 2021Series A$1M
- 2021Series A$8.8M
Investors
Refactor Capital, DCVC, Duquesne Family Office, Upside Vision Fund, Spearhead, Lauder Partners
Tech stack
Amazon Web ServicesApolloApple Icloud MailCloudflareCloudflare Bot ManagementContentful
#6
Series B · Austin, Texas · founded 2017 · 27 employees$20Mraised▾
Series B · Austin, Texas · founded 2017 · 27 employees
Developer of handheld PCR device for the detection of infectious disease. The device NUCLEIN uses standard real-time PCR, requires no technical expertise, battery-powered, results in one hour. This device can be used for covid diagnosis.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers
Activity: 1 expansions announced in 12 mo
Funding rounds
- Jul 2025Conventional Debt$19.1M
- Jan 2025Series B$9.4M
- Dec 2023Conventional Debt$8.8M
- Mar 2023Series B$4.2M
Founders & team
Investors
Trinity Investors
Tech stack
CloudflareCloudflare Bot ManagementCloudflare Browser InsightsComplianzCore-JsDivi
#7
Series A · Austin, Texas · founded 2015 · 13 employees$10.8Mraised▾
Series A · Austin, Texas · founded 2015 · 13 employees
Engineering personalized human blood to optimize cognitive performance and reverse Alzheimer's disease. The company claimed that it has successfully patented key innate immune system mimetics. The company's Heterochronic Optimized Plasma Exchange (HOPE) for Alzheimer’s.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Activity: 1 product launches · 1 partnerships (incl. Government of India) announced in 12 mo
Funding rounds
- Aug 2025Series A$20M
- Mar 2022Seed$10.8M
- Apr 2021Angel—
Investors
DecentraNet, Joseph Ventures, Keiretsu Forum, Star Lake Bioventures, Longevitytech.fund, Yucatan Rock
Tech stack
AngularCart FunctionalityCloudflareCore-JsGoogle AnalyticsGoogle Font Api
#8
Series A · Austin, Texas · founded 2016 · 43 employees$20Mraised▾
Series A · Austin, Texas · founded 2016 · 43 employees
Provider of a platform for process management software for pharma manufacturing. The software helps to create manufacturing processes for improved product quality. The platform follows Quality-by-Design (QbD) and Data Integrity-by-Design (DIbD) principles to enable the development of drugs, medical devices, and software. The platform also helps in identifying, ranking, and tracking risk factors.
Fliar Intelligence Index™ 42how this company ranks against its industry peers
Funding
top 36%Talent
top 38%Moat
top 39%Growth
top 45%Tech
top 49%Market
bottom 39%Funding: Raised $20.0M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) · Last round Series A (Apr 2025)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 7/10 · 9 curated direct competitors tracked
Audience (LinkedIn): 13k LinkedIn followers — 4.6% of this cohort's audience
Activity (LinkedIn): 1 partnerships · 1 awards (incl. AskBio Inc.) announced in 12 mo
Funding rounds
- Apr 2025Series A$13M
- Feb 2022Series A$15M
- Oct 2020Series A$2.1M
- Sep 2018Seed$500K
Founders & team
Investors
Northpond Ventures, S3 Ventures, Wanxiang Healthcare Investments, Hudson Park Advisors, Create Health, Zeeland Ventures
Tech stack
Amazon SesAmazon Web ServicesAnime.JsCloudflareCloudflare Bot ManagementComplianz
#9
Public · Austin, Texas · founded 1996 · 20 employees$23.6Mraised▾
Public · Austin, Texas · founded 1996 · 20 employees
Provider of therapeutics for multiple cancer treatments. It offers its propriety liposomal nanotechnology platform to help in the reformulation of cancer medicines and target drug delivery. Its leading candidate is DocePLUS which targets Small Cell Lung and others cancer Breast Ovarian Multiple Myeloma Kaposi's Sarcoma.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers
Activity: 1 partnerships (incl. Elevance Health) announced in 12 mo
Funding rounds
- Feb 2025Post IPO$3.7M
- Feb 2025Grant (prize money)$2M
- May 2024Post IPO—
- Aug 2022Grant (prize money)$17.6M
Founders & team
Investors
state.tx.us, AIGH Capital Management, Texas.gov
Tech stack
Acquia Cloud PlatformAcquia Cloud Site FactoryAdobe AnalyticsAdobe Experience Platform Identity ServiceAdobe Experience Platform LaunchAll In One Seo
#10
Series A · Austin, Texas · founded 2017$9.7Mraised▾
Series A · Austin, Texas · founded 2017
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery. The company's proprietary maging hardware combines the power of science and deep tech to develop intraoperative scanners to streamline surgeries in the operating room.
Fliar Intelligence Index™ 42how this company ranks against its industry peers
Talent
top 28%Innovation
top 30%Patents
top 32%Funding
top 36%Moat
top 38%Tech
bottom 44%Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Innovation: 17 patents (top 49% of patent-holders) · 17 filings since 2022 vs 0 in 2017-21 · Deep-tech classification: Tech Hardware
Patents: 17 patents matched (strict assignee match) · 17 filings since 2022 vs 0 in 2017-21 · Latest publication 2025
Funding rounds
- Apr 2025Series A$3M
- Nov 2023Series A$8.2M
- Feb 2021Series A—
- Aug 2020Series A—
Founders & team
Investors
MassChallenge, Capital Factory, Temple Health & Bioscience District, Epilepsy Foundation, Medingenii, Texas A&M New Ventures
#11
Series A · Austin, Texas · founded 2017 · 43 employees$5Mraised▾
Series A · Austin, Texas · founded 2017 · 43 employees
Developer of a clinical platform designed to accelerate clinical development. The platform provides functional capabilities supporting data standards, clinical lifecycle activities, and processes. It focuses on data, eliminates amendments, and automates data collection and analysis. The platform leverages a microservice architecture, allowing users to take advantage of applications.
Fliar Intelligence Index™ 40how this company ranks against its industry peers
Innovation
top 29%Patents
top 31%Moat
top 32%Funding
top 36%Product
top 36%Talent
bottom 49%Innovation: 24 patents (top 39% of patent-holders) · 24 filings since 2022 vs 0 in 2017-21 · 7 product lines
Patents: 24 patents matched (strict assignee match) · 24 filings since 2022 vs 0 in 2017-21 · Latest publication 2026
Moat: Editorial + unicorn rating 5/10 · IP moat: 24 patents
Audience (LinkedIn): 1k LinkedIn followers
Funding rounds
- Jul 2025Series A$1M
- Apr 2025Series A$460K
- Sep 2023Series A$5M
Founders & team
Investors
Simulations Plus, Archer Venture Capital
Tech stack
Apple Icloud MailCookie NoticeDiviGoogle AnalyticsGoogle Font ApiJquery
#12
Seed · Austin, Texas · founded 2012$1.7Mraised▾
Seed · Austin, Texas · founded 2012
Developing sustained drug delivery platform for ocular diseases, improving patient outcomes. The company focuses on creating non-invasive solutions for treating eye conditions, particularly glaucoma. Their technology, the Evolute® Punctal Plug Delivery System, aims to improve patient compliance and therapeutic outcomes by automatically delivering medication over an extended period, eliminating the need for eye drops. This innovative approach addresses the need for better management of ocular disorders and seeks to enhance the quality of life for individuals with vision impairment. The company is dedicated to delivering sustained therapy in ophthalmology to treat multiple ophthalmic disorders. This is a B2C healthcare solution.
Funding rounds
- Sep 2025Seed$2.2M
- May 2019Seed$165K
- Oct 2018Seed$50K
- Oct 2014Seed$150K
Founders & team
Tech stack
NginxModernizrJqueryGoogle Hosted LibrariesSucuri
Funding & investor landscape
$3.2Btotal disclosed funding
106companies funded
423disclosed rounds
0rounds last 90 days
Most active investors
Notable founders
Ross Johnson
Co-Founder · Pattern Bioscience
Nicolas Arab
Co-Founder & CEO · Pattern Bioscience
Skylar Talley
Co-Founder & CEO · MedScout
Alan Blake
Chief Executive Officer · Nuclein
Ryan Shillington
Co-Founder and CTO · QbDVision
Yash Sabharwal
Chief Executive Officer · QbDVision
Marc Hedrick
CEO · PLUS THERAPEUTICS
Aaron Bernstein
Co-Founder & CTO · VISIE
Patrick Edwards
Co-Founder · VISIE
Alex Lazar
Founder & President · Nurocor
Bob Butchofsky
Founder and CEO · Mati Therapeutics
Doug Stoakley
Co-Founder · ClearCam
Prism market signals · United States · country-scoped Prism corpus, 1,465,538 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH FROM Austin · institutions
What Austin researches in biotechnology
UT Austin and partners lead Austin's biotech research, focusing dominantly on DNA repair and PARP cancer therapy inhibition, with a cautiously optimistic tone (mean stance 0.53, breakthroughs outpacing concerns 17-to-6).
36 papersstance +0.5353% breakthrough19% concern
local research themes
DNA Repair MechanismsBacterial Genetics and BiotechnologyRNA and protein synthesis mechanismsPARP inhibition in cancer therapyvaccines and immunoinformatics approachesPlant-Microbe Interactions and Immunity
top institutions
- The University of Texas at Austin31
- Austin Health2
- Universidad Nacional José Faustino Sánchez Carrión1
- Austin Hospital1
- Austin College1
Common questions
How many Life Sciences companies are there in Austin, United States?
Radar tracks 221 indexable Life Sciences companies headquartered in Austin, United States that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Austin, United States?
The Life Sciences companies in Austin, United States on this list have raised a combined $3.2B in disclosed equity funding across 106 funded companies.
Which is the highest-funded Life Sciences company in Austin, United States?
Everlywell is the highest-funded Life Sciences company in Austin, United States, with $330M in disclosed equity funding.
How many Life Sciences companies in Austin, United States are funded?
106 of the 221 Life Sciences companies in Austin, United States on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Austin, United States?
1 Life Sciences company in Austin, United States on this list is valued at $1B or more.
Who are the top investors in Austin, United States Life Sciences companies?
The most active investors in Austin, United States Life Sciences companies on this list include HHS, Austin Technology Incubator, National Science Foundation, Capital Factory, Sante Ventures.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.